DE60132190T2 - Mutierte version der arginin deiminase - Google Patents

Mutierte version der arginin deiminase Download PDF

Info

Publication number
DE60132190T2
DE60132190T2 DE60132190T DE60132190T DE60132190T2 DE 60132190 T2 DE60132190 T2 DE 60132190T2 DE 60132190 T DE60132190 T DE 60132190T DE 60132190 T DE60132190 T DE 60132190T DE 60132190 T2 DE60132190 T2 DE 60132190T2
Authority
DE
Germany
Prior art keywords
arginine deiminase
modified
arginine
enzyme
deiminase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132190T
Other languages
German (de)
English (en)
Other versions
DE60132190D1 (de
Inventor
Charles Mark Lexington ENSOR
Frederick Wayne Nicholasville HOLTSBERG
Mike A. Lexington CLARK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Polaris Group Taiwan
Original Assignee
Polaris Group Taiwan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polaris Group Taiwan filed Critical Polaris Group Taiwan
Application granted granted Critical
Publication of DE60132190D1 publication Critical patent/DE60132190D1/de
Publication of DE60132190T2 publication Critical patent/DE60132190T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03006—Arginine deiminase (3.5.3.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Dairy Products (AREA)
DE60132190T 2000-05-04 2001-05-02 Mutierte version der arginin deiminase Expired - Lifetime DE60132190T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US564559 2000-05-04
US09/564,559 US6635462B1 (en) 1997-05-12 2000-05-04 Mutated form of arginine deiminase
PCT/US2001/014116 WO2001083774A2 (en) 2000-05-04 2001-05-02 Novel mutated form of arginine deiminase

Publications (2)

Publication Number Publication Date
DE60132190D1 DE60132190D1 (de) 2008-02-14
DE60132190T2 true DE60132190T2 (de) 2008-12-11

Family

ID=24254954

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132190T Expired - Lifetime DE60132190T2 (de) 2000-05-04 2001-05-02 Mutierte version der arginin deiminase

Country Status (11)

Country Link
US (2) US6635462B1 (enExample)
EP (1) EP1278868B9 (enExample)
JP (1) JP4709465B2 (enExample)
AT (1) ATE382697T1 (enExample)
AU (1) AU2001259353A1 (enExample)
CY (1) CY1107351T1 (enExample)
DE (1) DE60132190T2 (enExample)
DK (1) DK1278868T3 (enExample)
ES (1) ES2296750T3 (enExample)
PT (1) PT1278868E (enExample)
WO (1) WO2001083774A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
AU2003215272B2 (en) * 2002-02-14 2008-04-03 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
ES2477118T3 (es) * 2002-11-18 2014-07-15 Polaris Group Método para inhibir la replicaci�n viral in vivo
ATE554392T1 (de) 2002-11-20 2012-05-15 Univ Leland Stanford Junior Diagnoseverfahren für sprue/zöliakie
US7579313B2 (en) * 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
CN101002945B (zh) * 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
EP2136833B1 (en) * 2007-03-16 2019-05-01 The Board of Trustees of the Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
US8148105B2 (en) * 2007-03-16 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Scaleable manufacturing process for cysteine endoprotease B, isoform 2
EP2295560A1 (en) 2009-09-14 2011-03-16 RWTH Aachen University Directed evolution of arginine deiminase for increased activity at physiological pH
US10118754B2 (en) * 2011-11-22 2018-11-06 Kimberly-Clark Worldwide, Inc. Method of folding pant-like disposable absorbent garments in a chute
US11123230B2 (en) * 2011-11-22 2021-09-21 Kimberly-Clark Worldwide, Inc. Method of folding pant-like disposable absorbent garments in a chute
US9918881B2 (en) 2011-11-22 2018-03-20 Kimberly-Clark Worldwide, Inc. Method of folding pant-like disposable absorbent garments in a trough
JP2014521602A (ja) * 2012-04-04 2014-08-28 ポラリス グループ アルギニンデイミナーゼを用いる処置方法
WO2014151982A2 (en) 2013-03-15 2014-09-25 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi – peg 20 antibodies for cancer treatment
TWI676683B (zh) * 2014-03-14 2019-11-11 開曼群島商瑞華藥業集團 用於癌症治療之對ａｄｉ－ｐｅｇ２０抗體交叉反應性降低之精胺酸去亞胺酶
WO2015143006A1 (en) * 2014-03-18 2015-09-24 Tdw Group Engineered chimeric pegylated adi and methods of use
CA2961602A1 (en) 2014-09-16 2016-03-24 Polaris Group Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment
CN104726478A (zh) * 2015-03-09 2015-06-24 武汉远大弘元股份有限公司 表达精氨酸脱亚胺酶基因的重组大肠杆菌及其应用
US10435682B2 (en) 2016-02-19 2019-10-08 University Of South Florida Arginine deiminase gene therapy for disordered proteins
US12281339B2 (en) 2016-07-05 2025-04-22 Polaris Group Combination cancer immunotherapies with arginine depletion agents
EP3534963B1 (en) 2016-11-02 2024-04-17 Polaris Group Formulations of pegylated arginine deiminase
CN108265044B (zh) * 2016-12-31 2021-05-11 江苏众红生物工程创药研究院有限公司 聚乙二醇定点修饰的精氨酸脱亚胺酶及其制备方法与应用
CN112442496B (zh) * 2019-08-28 2023-05-12 江苏众红生物工程创药研究院有限公司 精氨酸脱亚胺酶突变体及其应用
CN118792288B (zh) * 2024-06-19 2025-03-04 中国医科大学附属第四医院 一种pH稳定性高的精氨酸脱亚胺酶突变体及其在肿瘤治疗中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
JP2900279B2 (ja) 1989-08-02 1999-06-02 株式会社ジャパンエナジー 新規なアルギニンデイミナーゼ、その製造法及び該酵素を有効成分とする制癌剤
JP2736145B2 (ja) 1990-01-11 1998-04-02 関東電化工業株式会社 パーハロゲン化エチレンの製造法
JP3209338B2 (ja) 1990-09-10 2001-09-17 株式会社ジャパンエナジー ポリエチレングリコール修飾アルギニンデイミナーゼおよびその製造法
US5372942A (en) 1992-02-10 1994-12-13 Coriell Institute For Medical Research Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
US5804183A (en) 1997-01-31 1998-09-08 Enzon, Inc. Arginine deminase derived from mycoplasma arthritidis and polymer conjugates containing the same
AU740207B2 (en) * 1997-02-06 2001-11-01 Novozymes A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
US6183738B1 (en) 1997-05-12 2001-02-06 Phoenix Pharamacologics, Inc. Modified arginine deiminase
US6180387B1 (en) 1997-08-11 2001-01-30 Smithkline Beecham Corporation Arginine deiminase

Also Published As

Publication number Publication date
US20040258675A1 (en) 2004-12-23
WO2001083774A3 (en) 2002-05-23
JP2003533186A (ja) 2003-11-11
US6635462B1 (en) 2003-10-21
EP1278868A2 (en) 2003-01-29
DK1278868T3 (da) 2008-05-19
EP1278868B9 (en) 2008-10-29
JP4709465B2 (ja) 2011-06-22
WO2001083774A2 (en) 2001-11-08
PT1278868E (pt) 2008-04-11
AU2001259353A1 (en) 2001-11-12
EP1278868B1 (en) 2008-01-02
CY1107351T1 (el) 2012-12-19
DE60132190D1 (de) 2008-02-14
ES2296750T3 (es) 2008-05-01
ATE382697T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
EP1278868B9 (en) Mutated form of arginine deiminase
DE69925917T2 (de) PEG-Urikase Konjugate und Verwendung davon
DE69835515T2 (de) Modifizierte arginindeiminase
DE69625085T2 (de) Konjugate eines polypeptids und eines biologisch verträglichem polymer
DE60029091T2 (de) Verfahren zur herstellung von diphtheria toxin
DE69430251T2 (de) Verbesserte interferon-polymerkonjugate
DE69133354T2 (de) Interleukin 1-beta protease und ihre inhibitoren
DE69233669T2 (de) Bakterielle nitroreduktase zur reduzierung von cb 1954 und analogen davon in eine zytotoxische form
DE69832993T2 (de) Arginin deiminase aus mycoplasma arthirtidis und sie enthaltende polymerkonjugate
DE69426300T2 (de) Modifikation von polymeren
DE69434332T2 (de) Thrombin mutanten
DE69004966T2 (de) Antikoagulierendes protein.
EP0200467B1 (en) Superoxide dismutase combined with a poly(alkylene oxide)
DE60319083T2 (de) Pharmazeutische verbindung und methoden zur behandlung von menschlichen karzinomen mittels arginin-entzug
DE69020276T2 (de) Amylose-Lysozym-Hybrid, ein Aktivzucker und Verfahren zur Herstellung.
DE69020979T2 (de) Neue Arginin-Deiminase, Verfahren zu ihrer Herstellung und ein Antikrebsmittel, das dieses Enzym als wirksamen Bestandteil enthält.
WO2013138731A1 (en) Polymeric conjugates of c1-inhibitors
DD264939A5 (de) Verfahren zur Herstellung einer Nucleinsäure
DE3854678T2 (de) Menschliches Mangansuperoxiddismutase und Behandlungsverfahren.
DE60037189T2 (de) Rekombinante, natrium-jodid symporter-kodierende adenoviren
DE69030553T2 (de) Verfahren zur Herstellung modifizierter Superoxid-Dismutase
CH676990A5 (enExample)
US10752672B1 (en) Recombinant hemoglobins and methods of preparation and use thereof
DE69408677T2 (de) Nickelfreier hämoglobin und verfahren zu seiner herstellung
DE69815769T2 (de) Antitumormittel enthaltend einen Komplex einer Oxidoreduktase und eines Polymers und ein Substrat des Enzyms

Legal Events

Date Code Title Description
8364 No opposition during term of opposition